Global Retirement Partners’s Ocular Therapeutix OCUL Stock Holding History

Global Retirement Partners’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$2.73K	Hold	225	–	–	﹤0.01%	3633
2025 Q3	$2.63K	Hold	225	–	–	﹤0.01%	3221
2025 Q2	$2.09K	Buy	+225	New	+$1.76K	﹤0.01%	3228
2024 Q4	$1.92K	Hold	225	–	–	﹤0.01%	3084
2024 Q3	$1.96K	Hold	225	–	–	﹤0.01%	2946
2024 Q2	$1.54K	Hold	225	–	–	﹤0.01%	3056
2024 Q1	$2.05K	Hold	225	–	–	﹤0.01%	2746
2023 Q4	$945	Hold	225	–	–	﹤0.01%	2920
2023 Q3	$621	Hold	225	–	–	﹤0.01%	2904
2023 Q2	$1.16K	Hold	225	–	–	﹤0.01%	2734
2023 Q1	$1.39K	Hold	225	–	–	﹤0.01%	2625
2022 Q4	$632	Hold	225	–	–	﹤0.01%	2703
2022 Q3	$1K	Hold	225	–	–	﹤0.01%	2534
2022 Q2	$1K	Hold	225	–	–	﹤0.01%	2500
2022 Q1	$1K	Hold	225	–	–	﹤0.01%	2466
2021 Q4	$2K	Hold	225	–	–	﹤0.01%	225
2021 Q3	$2K	Hold	225	–	–	﹤0.01%	1844
2021 Q2	$3K	Hold	225	–	–	﹤0.01%	1684
2021 Q1	$4K	Hold	225	–	–	﹤0.01%	1536
2020 Q4	$5K	Sell	225 -75	-25%	-$1.11K	﹤0.01%	1451
2020 Q3	$2K	Hold	300	–	–	﹤0.01%	1494
2020 Q2	$2K	Hold	300	–	–	﹤0.01%	1472
2020 Q1	$1K	Hold	300	–	–	﹤0.01%	1505
2019 Q4	$1K	Hold	300	–	–	﹤0.01%	1552
2019 Q3	$1K	Hold	300	–	–	﹤0.01%	1532
2019 Q2	$1K	Buy	+300	New	+$1.11K	﹤0.01%	1529

Other funds holding OCUL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Global Retirement Partners's OCUL Position: Q4 2025 in Review

Global Retirement Partners held its Ocular Therapeutix (OCUL) position steady in Q4 2025 at 225 shares worth $2.73K. The position accounts for ﹤0.01% of the portfolio, ranked #3633.

Global Retirement Partners first reported a position in OCUL in Q2 2019 and has held it in 26 quarters since. The position peaked at $5K in Q4 2020. 249 funds tracked by Wall St. Rank hold OCUL as of Q4 2025.

Global Retirement Partners held 225 shares of Ocular Therapeutix worth $2.73K as of Q4 2025.
Global Retirement Partners left its Ocular Therapeutix share count unchanged in Q4 2025.
Ocular Therapeutix made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3633 holding.
Global Retirement Partners first reported a position in Ocular Therapeutix in Q2 2019 and has held it in 26 quarters since.
Global Retirement Partners's Ocular Therapeutix position peaked at $5K in Q4 2020.
249 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.